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Yu Lung Lau1 and Wanling Yang1*Abstract
Human leukocyte antigen (HLA) typing from next generation sequencing (NGS) data has the potential for widespread
applications. Here we introduce a novel tool (HLAreporter) for HLA typing from NGS data based on read-mapping
using a comprehensive reference panel containing all known HLA alleles, followed by de novo assembly of
the gene-specific short reads. Accurate HLA typing at high-digit resolution was achieved when it was tested
on publicly available NGS data, outperforming other newly developed tools such as HLAminer and PHLAT.
HLAreporter can be downloaded from http://paed.hku.hk/genome/.Background
The human leukocyte antigens (HLAs) include a large
number of genes crucial to immune system function.
They play important roles in immune responses to infec-
tion, transplant rejection, pathogenesis of autoimmune
diseases, adverse drug reaction, and cancer development.
Thus, HLA typing is very important for both clinical la-
boratories and biomedical research. For example, HLA
is highly associated with many complex diseases such as
autoimmune disease and cancer and typing HLAs from
next-generation sequencing (NGS) data can have wide-
spread application in identifying the associated genes for
complex diseases. HLA is also the key for many adverse
drug responses and transplant rejection. Thus, typing HLA
from NGS data can at least serve as a preliminary popula-
tion screening tool to identify individuals who might have
potential adverse drug responses or are potential organ
donors, although exact clinical use would require more
stringent standards and procedures. Since having NGS
data for large numbers of healthy individuals is rapidly be-
coming a reality, the potential benefits of HLA screening
using this type of data is multi-fold.
However, HLA typing has always been challenging due
to the complexity of this group of genes, including the
existence of large number of alleles for most HLA genes,* Correspondence: yangwl@hku.hk
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unless otherwise stated.major sequence difference between these alleles, sequence
similarity among the paralogous HLA genes, and long
range linkage disequilibrium in this region [1,2]. For ex-
ample, for the HLA-DRB1 gene alone, over a thousand al-
leles have been reported in human populations according
to the IMGT/HLA database (IMGT/HLA 2012, release
3.10.0) [3]. In addition, many HLA-DRB5 alleles have
great sequence similarity to those of DRB1, adding more
difficulties for accurately calling HLA alleles from sequen-
cing data [4].
HLA typing has been done via various technologies,
such as serological, cellular, and molecular assays [5].
Sequencing-based methods have been rapidly gaining
popularity due to technology advancement, especially in
research settings. With the development of NGS, large
amounts of sequencing data are becoming widely avail-
able. Although most the data were not generated for this
purpose, they still provide valuable resources for HLA
typing. NGS data might be useful in multiple contexts,
such as preliminary screening for potential organ donors
or for individuals that are potentially susceptible to ad-
verse drug responses, for risk prediction for complex
diseases, and population genetic studies [6,7]. They also
provide much more comprehensive information on this
region than any other traditional methods of HLA typ-
ing, potentially useful in sorting out the complex struc-
ture of the genetic variants in this region.
However, due to the complexity of the HLA loci, the
large amount of NGS data has not yet been renderedThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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forts have been made by mining NGS data, including the
alignment-based method that relies on counting the
number of short reads aligned to each specific allele [8],
the assembly- and scoring-based method that takes into
account good quality contigs and their scores for each
candidate HLA allele [9]. These methods capitalize on
the increasing accessibility and affordability of NGS se-
quencing and have greatly reduced the time and cost re-
quired to make an HLA call compared with traditional
standard PCR-based solutions. Unfortunately, all these
methods are only capable of achieving low-digit resolution
and perform poorly at higher-digit resolution, which is re-
quired for clinical applications.
In this study, we introduce a novel approach for accur-
ate HLA typing at high-digit resolution based on a strat-
egy of comparing sequence reads with a comprehensive
reference panel containing all the known HLA alleles for
high efficiency mapping, followed by assembly of the
mapped reads to contigs, stepwise matching and designa-
tion of the contigs to HLA alleles and decision on HLA al-
lele calling. Testing of the method on a set of public and
internal whole exome sequencing (WES) data demon-
strated that this new method is capable of reporting HLA
alleles at high-digit resolution with great accuracy. We
also conducted a preliminary analysis of WES data from
149 NGS samples generated in-house. HLA calling results
demonstrated consistent allele frequencies to those re-
corded in the Allele Frequency Net Database (AFND) [10]
of the same population. Certain long range HLA haplo-
types across class I and II genes reported in AFND were
also observed in our dataset. These preliminary results
highlight the potential applications of this method for
HLA calling from NGS data, which may have significant
implications in many important clinical contexts.
Methods
Classification of short sequencing reads to specific HLA
genes through mapping using a comprehensive reference
panel
In order to achieve accurate HLA typing, the first essential
step is to accurately classify the short sequencing reads
with regard to the specific HLA genes they are derived
from. Many of the short sequencing reads from HLA genes
are not mapped properly or are labeled as unmapped for
most NGS data processing procedures due to great allelic
differences and sequence similarity between paralogous
genes. Recognizing this, we designed a comprehensive ref-
erence panel (CRP) for classifying reads according to their
corresponding HLA genes. Allele differences were fully
accounted for during mapping by adopting all the known
HLA alleles in the IMGT/HLA database as references,
which ensured complete capture of the HLA reads for fur-
ther analysis and accurate classification. Mapping wasperformed using Burrows-Wheeler Aligner (BWA) v.0.6.1
[11] with default parameters, using all the raw reads from
fastq file for NGS data against all the reference sequences
in the CRP. In this work, we mainly considered a gene’s
polymorphic exons for HLA typing (exons 2, 3, and 4 for
class I genes HLA-A, HLA-B, and HLA-C, and exons 2
and 3 for the class II genes). In order to capture reads con-
taining partial intron sequences, a comprehensive panel
of references was designed by appending 50 bp of in-
tron sequences extracted from the IMGT/HLA database
to sequences from both ends of a reference exon. For
the alleles without intron sequence information in the
IMGT/HLA database, corresponding intron sequences
from other alleles of the same gene were used to include
intron sequences at the junctions. As a result, the panel is
capable of capturing short reads partly falling outside of
the targeted exons by as many as 50 bp, for mapping from
both WES and whole genome sequencing (WGS) data.
In addition to the targeted genes that we aimed to type
(that is, HLA-A, −B, −C, −DRB1, −DQB1, −DQA1,
−DPB1, −DRB3, 4, 5), we also included all known allelic
sequences of a set of minor HLA genes (that is, HLA-E,
−F, −G, −H, −J, −K, −L, −V, −P, −DMA, −DMB, −DOA,
−DOB, −DPA1, −DRA) in the CRP panel for mapping
accuracy. These genes serve as ‘mapping competitors’ to
ensure accurate mapping of the sequencing reads. After
classification, short reads mapped to a specific gene were
collected in order to assemble them into contigs for fur-
ther analysis (Figure 1).
We excluded those ambiguous reads where a short
read mapped to a gene from the mapping panel could
also be perfectly mapped to another gene. Reads with
equal mapping score towards multiple genes but with
imperfect sequence alignment were retained for further
analysis since this level of similarity is expected among
different HLA genes. The short reads mapped to a par-
ticular HLA gene were assembled respectively using de
novo assembly. An assembler called TASR [9] was used
here for the de novo assembly (for a detailed description
of the TASR algorithm see Warren et al. [9]). During
this process, only reads with a 100% match in the over-
lapped region were assembled. On average, 30% of short
reads with mismatches would have to be excluded based
on the NGS data used in this study, effectively eliminat-
ing potential effects of sequencing error on assembly.
Design of reference database of HLA alleles for matching
assembled contigs
We designed two reference databases of HLA alleles for
matching the assembled contigs to the corresponding HLA
alleles, one with sequences for the major polymorphic
exons (exons 2 and 3 for class I genes and exon 2 for class
II genes) and one with additional sequences for the minor
polymorphic exons (exon 4 for class I genes and exon 3
Figure 1 HLAreporter detection flow using the HLA-DRB1 gene as an example. Classification of reads to a specific gene using CRP
panel-based mapping is shown in stages 1 and 2. Assembly and contig-HLA matching are shown in stages 3, 4, and 5.
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signed was the major database (mDB), which contains se-
quence information of all the known alleles on the major
polymorphic exons from the IMGT/HLA database, and
this database is queried first using each assembled contig
(exons 2 and 3 for class I genes and exon 2 for class II
genes). When multiple HLA alleles have identical nucleo-
tide sequences across the major exons, an upper case ‘G’
is appended to their names as a suffix based on HLA no-
menclature [12] and these alleles are further examined.
Unlike the CRP, which was designed for mapping of the
sequencing reads that may contain intron sequences, thereference database here does not contain intron exten-
sions, and no ‘competitor sequences’ are included.
The second reference database is designated the add-
itional database (aDB), which records the minor poly-
morphic exon sequences for all the ‘G’ group alleles. When
a specific allele cannot be designated via mDB, the contigs
corresponding to minor exon sequences are examined by
aligning them to the candidate alleles in aDB. We sepa-
rated the minor exons from the major ones since a number
of alleles in the IMGT/HLA database do not have informa-
tion on the minor exons. This design also enhances the ef-
ficiency of the analysis on the assembled contigs.
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To assign candidate alleles to the assembled contigs, the
targeted contigs are then matched to the sequences in
the two databases, mDB and aDB, sequentially. To guar-
antee accuracy, a stringent standard is adopted during the
contig-HLA allele matching process, where only a perfect
match to the candidate alleles on the exonic regions is
considered. Contigs supported by an average read cover-
age depth of less than five-fold are also excluded since
contigs with lower depth might be less reliable. All contigs
with different lengths supported by an average depth
of five-fold or above are considered in cases where
not enough long contigs could be generated by the as-
sembler for certain HLA alleles. By analyzing all the as-
sembled contigs using a scoring system based on the
length of the contig in the exonic region and the coverage
depth, the candidate HLA alleles that match those assem-
bled contigs are assigned (for the scoring system and the
assignment algorithm see Warren et al. [9]). Briefly, the
score of a contig is the product of the contig size (base
pairs), the average coverage depth of the contig, and the
percentage of the contig’s exonic sequence. Accordingly,
the score of an allele supported by multiple contigs (for
example, exons 2 and 3 for class I genes) is the sum of the
contig scores. Each candidate allele is measured by the
corresponding contig scores and is sorted in a descending
order. Based on the sorted scores, HLA alleles are re-
ported whenever a uniquely matched contig that has not
already been assigned is detected. The overall flow of this
technique is presented in Figure 1.
Since we only allowed for perfect matches between as-
sembled contigs and the HLA alleles in the database,
any assembled contigs with mismatches were not con-
sidered at this step. For the purpose of novel allele de-
tection, HLAreporter would document all the assembled
contigs for the main exons, and report these contigs and
their quality to users so that further analysis of them
could reveal novel alleles. Similarly, sample contamin-
ation may introduce a third or fourth HLA allele for a
given gene and this will also be documented for the
user’s attention.
Application of HLAreporter on whole exome sequencing
data
Data from 82 samples with a total of 791 verified HLA
alleles using experimental methods were selected to test
the performance of HLAreporter, including 62 publicly
available samples [1,13-15] and 20 internal samples from
the Thai population (downloadable from [16]). WES data
in fastq format were downloaded from the 1000 Genomes
Project [17] and the HapMap Project [18]. Of the 62 pub-
lic samples, the 11 samples from 1000 Genomes Project
were generated using Illumina GAIIx and allelic HLA
typing was performed using SeCore HLA SequencingReagents (Life Technologies Corporation, Grand Island,
New York, USA). The 51 HapMap samples were released
in 2013 by the Baylor College of Medicine (BCM) and
Washington University Genome Sequencing Center
(WUGSC). We selected these samples because they have
publicly available calls on HLA class I and class II genes
and relatively longer read length and higher coverage
depth, a feature of the more recently released samples.
The details of the WES data, including 62 publicly avail-
able samples with 711 verified HLA types, can be found in
Table S1 in Additional file 1.
A preliminary analysis of in-house WES data on the
Hong Kong population was also conducted using
HLAreporter. The raw data in fastq format were gener-
ated using Illumina HiSeq 1500 with a read length ranging
from 90 to 101 bases. A total of 149 Hong Kong Chinese
samples were included, each of which is an independent
founder individual. There is no known association be-
tween the conditions of these individuals and HLA alleles
and the details of these 149 samples can be found in
Table S1 in Additional file 1. The WES data are accessible
through our website.
Using NGS data for HLA typing, there could be phasing
ambiguities. For those HLA genes with phasing issues, al-
leles with higher frequency in the public database were
assigned over those with lower population frequencies.
For example, allele pairs (A*02:03:01G; A*31:01:02G) and
(A*02:152; A*unknown-allele) could both explain the ob-
served genotypes for an individual due to phasing ambigu-
ity. Since A*02:152 has a much lower frequency than
A*02:03:01G and there is also an unknown allele with 0
reported population frequency in the IMGT/HLA data-
base, allele pair (A*02:03:01G; A*31:01:02G) would be
assigned here.
We used PHASE version 2 [19] to predict long range
HLA haplotypes. PHASE is a widely used tool that makes
use of Bayesian methods for haplotype reconstruction
and recombination rate estimation from population
data. PHASE supports SNPs as input; therefore, we
treated each HLA allele as if it is a SNP allele to run
PHASE. The top 50 alleles for each HLA gene based
on their population allele frequency were included as
index alleles for phasing as there is an allele number
limit allowed for PHASE. Then we used these indexes
to represent HLA alleles and ran multi-allelic phasing
to obtain the long range haplotypes.
This study is conducted in compliance with the Helsinki
Declaration (Edinburgh, October 2000) and in accordance
with local legislation. The research is approved by the In-
stitutional Review Board of the University of Hong Kong
and Hospital Authority Hong Kong West Cluster, as well
as the Institutional Review Board of Chulalongkorn
University Faculty of Medicine, Bangkok, Thailand. All par-
ticipants gave informed consent to take part in the study.
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Mapping efficiency
In this method, a CRP was used for short read collection
for HLA genes. To study the mapping efficiency for this
group of genes, we compared the number of reads cap-
tured for the HLA-DRB1 gene using a traditional single
reference-based mapping method and the CRP-based
mapping developed in this study, using BWA as the
mapping tool in both cases.
As can be seen in Figure 2a, compared with using single
reference hg19 only during mapping, sample SRR360148,
whose DRB1 alleles are *01:01 and *15:01, was more ef-
fectively mapped by a reference panel with multiple alleles
corresponding to the eight haplotypes in hg38, namely
APD, COX, DDB, MANN, MCF, QBL, SSTO, and PGF
(the allele for hg19). The short reads matching the two
DRB1 alleles *01:01 and *15:01 were better captured by
the multiple reference panel, even though allele *01:01
was still underrepresented by the eight-haplotype panel
and far fewer short reads were captured compared with
those corresponding to allele PGF (*15:01). Clearly, using
a single allele hg19 *15:01:01:01 as the reference can only
capture those short reads similar to itself, which would re-
sult in a loss of short reads derived from allele *01:01 and
an incorrect DRB1 designation.
Figure 2b summarizes the total number of reads cap-
tured for samples SRR360148 and SRR359103. Using a
single allele as the mapping reference, as done by most
WES processing tools, would lose quite a number of
short reads and likely result in incorrect HLA typing.
For SRR360148, the number of short reads that a singleFigure 2 Mapping efficiency for HLA-DRB1 genes. Sample SRR360148 i
SRR359103 is heterozygote with alleles DRB1*03:01 and DRB1*07:01. (a) Dif
sample SRR360148. Clearly a multiple allele-based mapping panel that con
hg19*15:01:01:01 (that is, PGF). (b) The total number of reads captured usin
reference panel for samples SRR360148 and SRR359103. Using one mapreference can capture amounts to only about 75% of that
captured by the multiple allele reference panel. The differ-
ences were much greater for sample SRR359103, which
has alleles DRB1*03:01 and *07:01 for this gene, where the
majority of sequence reads were not captured using refer-
ence hg19 *15:01:01:01. This resulted in an HLA detection
failure for this sample when we used those reads for HLA
typing, emphasizing the deficiency of traditional mapping
approaches for HLA detection.
Predictions of HLA class II genes
Predictions of HLA class I and class II genes for the 11
publicly available 1000 Genomes samples with adequate
NGS data are presented in Table 1 (a description of data
quality is presented in Table S1 in Additional file 1).
Results for 51 additional HapMap samples and 20 in-
ternal Thai samples are shown in Table S2 in Additional
file 1. Predictions made by HLAminer [9] using de
novo assembly are also shown as a comparison. The
columns ‘HLA-DQB1(exon 2)’ and ‘HLA-DQB1 (exon
2&3)’ represent predictions made by examining exon 2
only and predictions after further examining exon 3,
respectively.
As we can see from Table 1, for HLA class II genes,
our results show complete consistency with the reported
alleles at the four-digit resolution (the 110 known HLA
types are presented in Table S1 in Additional file 1). In
contrast, HLAminer mistyped heterozygosity to homozy-
gosity in the case of SRR360288, failed to achieve four-
digit resolution in the case of SRR360655, and reported an
incorrect result at two-digit resolution in the case ofs heterozygote with alleles DRB1*01:01 and DRB1*15:01. Sample
ference in the number of reads captured on the exon 2 region for
tains eight different alleles of HLA-DRB1 outperforms a single reference
g hg19*15:01:01:01 as reference only versus a multiple allele-based
ping reference would lose quite a number of short reads.
Table 1 HLA predictions of class I and class II genes
HLAminer HLAreporter HLAminer HLAreporter HLAminer HLAreporter HLAminer HLAreporter DRB1 HLAminer HLAreporter DQB1
ID (SRR)a HLA-A HLA-A HLA-B HLA-B HLA-C HLA-C HLA-DRB1 DRB1(exon 2) (exon 2&3)b HLA-DQB1 DQB1 (exon 2) (exon 2&3)b
359102 *30:01; *30:02;
*30:04; *66:01
*30:02:01G;
*66:01:01G
*15:83; *18:01;
*18:26; *41:01;
*45:01; *50:01
*18:01:01G;
*41:02:01
*05:01; *17:01 *05:01:01G;
*17:01:01G
*03:01; *07:01 *03:01:01G *03:01:01 *02:01 *02:01:01G *02:01:01
359103 *01:01; *01:03;
*02:01; *02:03;
*11:02; *68:08
*01:01:01G;
*02:01:01G
*18:01; *18:03;
*57:01
*18:01:01G;
*57:01:01G
*07:01 *07:01:01G *03:01; *07:01 *03:01:01G;
*07:01:01G
*03:01:01;
*07:01:01
*02:01;
*03:03
*02:01:01G;
*03:03:02G
*02:01:01;
*03:03:02
359108 - *03:01:01G;
*68:02:01Gp
- *35:01:01G;
*53:01:01
*04:01 *04:01:01G - *04:05:01;
*08:04:01
*04:05:01;
*08:04:01
- *03:01:01G;
*03:02:01G
*03:01:04;
*03:02:01
359298 *11:01; *11:02;
*11:50; *24:02;
*24:07; *24:20c
*11:02:01G;
*24:07p
*27:04; *27:25;
*39:34; *40:02;
*40:06
*27:04:01G;
*39:05:01
*08:01; *08:21;
*12:02; *12:03
*08:01:01G;
*12:02:01Gp
*04:03; *08:03;
*12:01; *14:54c
*08:03:02;
*12:02:01
*08:03:02;
*12:02:01
*03:01; *06:01 *03:01:01G;
*06:01:01G
*03:01:01;
*06:01:01
359295 *02:03; *03:01 *02:03:01G;
*03:01:01Gp
*35:01; *35:03;
*37:01; *55:02;
*55:48; *56:01
*35:03:01G;
*55:02:01Gp
*01:02; *04:01;
*04:03; *12:03;
*15:02; *15:16c
*04:01:01G;
*12:03:01G
*04:03; *07:01;
*08:03; *14:05
*08:02:01;
*14:05:01
*08:02:01;
*14:05:01
*03:02; *03:03;
*03:05; *05:03
*04:02:01;
*05:03:01G
*04:02:01;
*05:03:01
360655 *30:01; *30:02;
*30:04; *32:01;
*74:01; *74:11
*30:02:01G;
*74:01:01G
*15:03; *57:01;
*57:06; *57:11
*15:03:01G;
*57:03:01p
*02:02; *02:11;
*07:01
*02:10;
*07:01:01Gp
*07:01; *08:03;
*11:01; *13:02
*11:01:02;
*13:02:01
*11:01:02;
*13:02:01
*05:01; *05:03;
*06:09
*05:02:01G;
*06:09:01
*05:02:01;
*06:09:01
360288 *02:01 *02:01:01G;
*02:11:01G
*15:01; *15:07;
*15:32; *35:14;
*58:01
*15:04;
*35:05:01
*01:02; *04:01;
*04:03; *04:06
*01:02:01G;
*04:01:01G
*04:03; *07:01 *04:11:01;
*09:01:02
*04:11:01;
*09:01:02
*03:02 *03:02:01G;
*03:03:02G
*03:02:01;
*03:03:02
360391 *02:01; *02:48;
*68:01
*02:01:01G;
*68:01:02Gp
*07:02; *40:02;
*40:06
*07:02:01G;
*40:02:01Gp
*03:03; *03:04;
*07:02
*03:04:01G;
*07:02:01Gp
*01:01; *07:01 *01:03;
*09:01:02
*01:03;
*09:01:02
*03:03; *05:01 *03:03:02G;
*05:01:01G
*03:03:02;
*05:01:01
360148 *01:01; *02:01;
*36:01
*02:01:01G;
*36:01
*07:02; *35:01;
*35:41; *40:01;
*40:79; *53:01c
*35:01:01G;
*40:01:01Gp
*03:02; *03:04;
*04:01; *04:03;
*15:02; *15:17c
*03:04:01G;
*04:01:01G
*01:01; *01:02;
*07:01; *15:01
*01:01:01G;
*15:01:01G
*01:01:01;
*15:01:01
*05:01; *06:02 *06:02:01G;
*05:01:01G
*06:02:01;
*05:01:01
359301 *02:03; *11:02;
*31:01; *32:01;
*74:01; *74:11
*02:03:01G;
*31:01:02Gp
*13:01; *48:01 *13:01:01G;
*48:01:01G
*03:03; *03:04 *03:03:01G;
*03:04:01G
*07:01; *08:03;
*11:01
*11:01:01G;
*13:12:01
*11:01:01;
*13:12:01
*03:01 *03:01:01G *03:01:01
359098 - *03:01:01G;
*68:02:01Gp
- *35:01:01G;
*53:01:01
*04:01 *04:01:01G - *04:05:01;
*08:04:01
*04:05:01;
*08:04:01
- *03:01:01G;
*03:02:01G
*03:01:04;
*03:02:01
a‘SRR’ is the prefix of each sample name, which is not explicitly shown in the table due to space limitations. bAll alleles with identical exon 2 and 3 sequences are reported. For example, after examining exons 2 and 3
of allele DQB1*03:03:02G, HLAreporter reports alleles 03:03:02:01/03:03:02:02/03:03:02:03. Since the last two digits out of eight digit-based HLA nomenclature are determined by intronic sequences, we only present the
first six digits *03:03:02 in the table after examining the minor exon. cAdditional ambiguity at four-digit resolution is not shown. pPhase was reported.
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Huang et al. Genome Medicine  (2015) 7:25 Page 7 of 12SRR359295, just to give a few examples. It is observed
that, for some class II alleles, examining exon 2 se-
quences alone would be sufficient (for example, for
DQB1*06:09:01, polymorphism is not currently found
in any other exons or introns except exon 2). While for
the alleles with identical exon 2 sequences but differences
in other exons, further examination of the exon 3 region
would be necessary.
Typing results on HLA class I genes
While accurate predictions without ambiguity were
achieved for HLA class II genes in all the samples
checked, HLA typing of class I alleles appeared to be
more affected by phase ambiguity. Generally, phase be-
comes an issue when the size of the non-polymorphic
gap between any two alleles is greater than the read
length, since different combinations could result in dif-
ferent alleles. We would report this phase ambiguity to
users so that further measures can be taken accordingly
(Table S3 in Additional file 1). We adopted the same
measures as in HLAminer by Warren et al. [9], that is,
sensitivity, specificity, and ambiguity as assessment met-
rics. To summarize, for HLAminer, sensitivity, specifi-
city, and ambiguity on this group of genes were 85%,
88%, and 56%, respectively. Of 66 class I alleles tested,
25 alleles (38%) were accurately reported by HLAminer
without ambiguity. On the other hand, although with
phase issues on ambiguous haplotypes, all predictions
made by HLAreporter were consistent with the reported
HLA alleles at the four-digit resolution.Table 2 Statistics of HLA typing results from 51 HapMap sam
Quality standard (QS)a HLA gene Total number of genes Num
10 × = 100% and 20× ≥98% HLA-A 51 3
HLA-B 51 7
HLA-C 51 4
HLA-DRB1 46 28
HLA-DQB1 51 20
HLA-DQA1 51 20
10 × = 100% and 20× ≥90% HLA-A 51 18
HLA-B 51 18
HLA-C 51 11
HLA-DRB1 46 40
HLA-DQB1 51 27
HLA-DQA1 51 35
10× ≥95% HLA-DRB1 46 45
HLA-DQB1 51 46
HLA-DQA1 51 43
aQuality standard (QS) ‘10 × ’ represents the percentage of locations with coverage
means the pre-defined percentage (that is, ‘10 × ’) is 95% or above. (‘20 × ’ has a sim
of HLA calls at four-digit (two-digit) resolution without ambiguity divided by the toPrediction accuracy
Thus, the reliability of this tool was verified using the
110 HLA alleles from 1000 Genomes samples, whose
typing was determined through standard PCR-based
methods. In addition, the 51 HapMap samples and 20
internal samples from the Thai population were also
tested. The HLA predictions were completely consistent
with the experiment-based typing results for all the sam-
ples that passed our quality test. Table 2 presents the
statistics for the HapMap samples with 601 known HLA
alleles. With 20-fold coverage depth for 98% of the se-
quences in the exonic region, we achieved 100% typing
accuracy at a four-digit resolution for all HLA genes
(Table 2, row ‘10 × = 100% and 20× ≥98%’). When the
quality standard was reduced to 90% of the exonic regions
with coverage of 20-fold (Table 2, row ‘10 × = 100% and
20× ≥90%’), we still achieved respectable performance at
the four-digit resolution, particularly for class II genes (ac-
curacy > 99%). Although there were certain ambiguities at
the four-digit resolution, at the two-digit resolution, accur-
acy remained at 100%. HLA-DQA1 apparently is the most
tolerant gene to low data quality, demonstrating 100% ac-
curacy at the four-digit resolution even when the quality
standard was reduced to 95% of the regions with only 10-
fold coverage depth (Table 2). This is probably due to the
least polymorphic nature of this HLA gene. HLA-DRB1 and
-DQB1 failed to achieve 100% accuracy at two-digit reso-
lution under this lower coverage depth, where three genes
were mistyped as homozygous since one of the two alleles
was missed in each case (Table S2 in Additional file 1).ples
ber of QS passesa Pass QS (%)a Four-digit (%)b Two-digit (%)b
6% 100% 100%
14% 100% 100%
8% 100% 100%
61% 100% 100%
39% 100% 100%
39% 100% 100%
35% 81% 100%
35% 83% 100%
22% 100% 100%
87% 99% 100%
53% 100% 100%
69% 100% 100%
98% 96% 98%
90% 91% 99%
84% 100% 100%
depth greater than 10-fold on the targeted exon. Accordingly, ‘10× ≥95%’
ilar definition). bThe four-digit (two-digit) percentage is equal to the number
tal number of alleles.
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known HLA types were tested using HLAreporter. With
a 20-fold coverage quality standard for most targeted ex-
onic sequences (that is, row ‘10 × = 100% and 20× ≥98%’
in Table 2), all 288 alleles (36% of all the tested alleles)
that passed the quality threshold were correctly typed at
four-digit resolution. Using a more lenient quality stand-
ard for the less polymorphic class II genes (90% of the
regions with coverage of 20-fold), of all the 370 alleles
(47% of all the tested alleles), only one HLA-DRB1 allele
was ambiguous at the four-digit resolution, while the other
369 alleles were correctly typed. Based on these results,
for HLAreporter, calls made based on coverage lower than
20-fold in more than 2% of the exonic sequences will be
accompanied with a warning sign for the user to check the
quality of the call. Since NGS is becoming more and more
accurate and with higher coverage depth, our algorithm is
advantageous with its call accuracy despite its demand on
data coverage and quality.
For the 149 samples whose data were produced in house,
we did not have HLA allele information available. To fur-
ther test the accuracy of HLA typing by HLAreporter, we
randomly chose five samples and performed PCR amplifi-
cation and Sanger sequencing on HLA-DRB1 exon 2. The
HLA typing results show complete consistency with our
predictions (result for sample PaedA51 is shown as an ex-
ample in Figure S1 in Additional file 1).
During the assembly process, only reads with a 100%
match in the overlapped region were assembled, elimin-
ating potential effects of sequencing errors on assembly.
In addition, all predictions were based on the assembled
contigs that have perfect match with sequences in the
IMGT/HLA database in the exonic regions. We also checked
the quality of assembled contigs on the exon 2 region that
supported the typing results of the HLA-DRB1 gene
for three samples. We observed that most predictions
achieved a coverage depth of 15-fold or above, suggesting
reliable predictions. A balanced coverage of the two alleles
in each case was also achieved (Table S4 in Additional
file 1). Further, we examined the coverage of this region
using the Integrative Genomics Viewer (IGV), a tool that
allows viewing of the short reads mapped to the targeted
exons. And the read patterns observed using the Integrative
Genomics Viewer demonstrated consistency with the pre-
dicted results (Figure S2 in Additional file 1).
HLA profiles detected in the Hong Kong Chinese
population
We used data from the 149 samples generated in-house
to study the HLA profiles in the Hong Kong Chinese
population. Distribution of HLA-DRB1 alleles is pre-
sented in Figure 3a and the distributions of other HLA
genes are shown in Figure S3 in Additional file 1. Allele
frequencies in a China Canton Han population with 264individuals are also presented (derived from [20]). Ac-
cording to their descriptions, the HLA alleles were typed
using the PCR sequence-specific oligonucleotide probe
(SSOP) typing method. The database provides allele informa-
tion with four-digit resolution (for example, DRB1*03:01),
so we used the alleles with the same first four digits
for comparison (for example, DRB1*03:01:01G versus
DRB1*03:01 in the database). The top three DRB1 al-
leles with highest frequencies are *09:01:02, *12:02:01, and
*15:01:01G. Indeed, these alleles are known to be common
in Asian populations (for the AFND Canton Han popula-
tion,*09:01, 14%; *12:02, 13%; *15:01, 10%). Compared
with records in AFND on Europeans, some population
differences in allele frequencies were observed, such as
those for *12:02 and *12:01. While European populations
have a higher frequency for *12:01, Hong Kong Chinese
have a five times higher frequency for *12:02.
From alleles to haplotypes
Figure 3b presents the prediction of major DRB1-DQB1
haplotypes calculated by PHASE. The haplotype distri-
bution is also compared with that provided in the AFND
database on matched populations. The major haplotypes
DRB1*09:01:02-DQB1*03:03:02G and DRB1*12:02:01-
DQB1*03:01:01G were clearly observed with the highest
frequency in our data, consistent with the record in
AFND.
Notably, strong linkage disequilibrium of the HLA
genes across a long distance was observed. For example,
the DRB1*09:01:02 and DQB1*03:03:02G alleles (Figure S3
in Additional file 1) both have an allele frequency of 13.5%
in Hong Kong Chinese, while haplotype DRB1*09:01:02-
DQB1*03:03:02G also presented with a frequency at about
13.5%, indicating that these two alleles have near absolute
linkage disequilibrium with each other. Likewise, haplo-
type DRB1*12:02:01-DQB1*03:01:01G has nearly the same
frequency as allele DRB1*12:02:01. Long range haplotypes
might play an important role in disease association and
drug response; thus, phasing these haplotypes for the
HLA alleles is necessary in association studies.
Discussion
We have shown that our approach is efficient for HLA
typing from whole exome sequencing data. The reliability
of this tool is verified by testing 791 known HLA class I
and class II alleles from 82 samples, whose HLA alleles
were experimentally confirmed. To achieve reliable predic-
tions, a stringent assembly procedure was conducted to
form contigs (zero mismatch tolerance), followed by a
stringent HLA assignment process to assign alleles (zero
mismatch tolerance on exonic regions), processes that
would ensure accuracy for HLA calls.
Since the proposed technique relies on de novo assem-
bly, read length is critical for typing accuracy. A shorter
Figure 3 HLA distribution profiles. (a) Allele frequency distribution of HLA-DRB1 in the Hong Kong (HK) Chinese and China Canton Han populations.
(b) Haplotype frequency distribution of DRB1-DQB1 in the Hong Kong Chinese and China Canton Han populations.
Huang et al. Genome Medicine  (2015) 7:25 Page 9 of 12read length would worsen the phase issue. Generally, phase
becomes an issue when the size of the non-polymorphic
gap between any two alleles is greater than the read length
(100 bp in our tested 1000 Genomes data), since different
combinations might result in different alleles. In addition,
phase also becomes an issue when sequences between
two exons could have different combinations, which
has been reported in the IMGT/HLA database. For ex-
ample, for HLA alleles C*08:21, C*08:01:01G, C*08:16:01,
C*12:02:01G, and C*12:49, there is a 110 bp gap within
exon 2 and an inter-exon gap between exon 2 and exon 3,
with different combinations specifying different alleles.
Apparently this problem cannot be solved by the current
sequencing technology using short reads and paired-end
information of reads can only partially alleviate the
problem. While class II genes seem to have little phase
problem, class I gene typing is significantly affected by
this issue.To achieve high accuracy, data with good coverage on
HLA genes are also essential. A depth test on each exon
of the targeted gene is necessary to ensure accurate typ-
ing. If sequencing reads were poorly captured during the
enrichment process on exonic fragments, it would be
unlikely to properly detect HLA alleles. While there is
no golden standard, 30-fold depth on every location of
the targeted exons is recommended for adequate cover-
age and HLA calls (Figure S4 in Additional file 1). Bal-
anced capture of the different alleles is also important, a
process that should be considered during the design of
the probes for enriching exonic genomic fragments. In
the 82 real samples we tested, it was shown that 20-fold
depth on every targeted location could reach 100% accur-
acy at four-digit resolution. Lower coverage depth would
increase the risk of either failing to make a call or missing
one of the two alleles, calling homozygous on a heterozy-
gous genotype.
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quences for HLA typing by classification of sequencing
reads using a comprehensive reference-based mapping
strategy. We have shown that a traditional mapping ap-
proach using a single sequence as reference is incapable
of dealing with the great allelic differences of HLA
genes, with a large number of sequencing reads being
missed. The comprehensive mapping panel guarantees a
full information retrieval from the source data. Classifi-
cation of sequencing reads to a specific gene first helps
avoid the difficulty of de novo assembly using all the se-
quencing reads. HLAreporter also documents the assem-
bled contigs without 100% match to the candidate alleles
in the designated database, so it provides a chance of
novel allele detection, making full use of the advantages
that the NGS technology can bring.
During the revision of this article, Major et al. [21]
and Bai et al. [15] developed two algorithms for HLA
typing from NGS data, respectively. The two up-to-date
algorithms are both based on an alignment strategy
without performing contig assembly, which aim at typ-
ing HLA from different NGS data with distinct read
lengths, region coverage, and coverage depth. Bai et al.’s
algorithm PHLAT reported 93% accuracy for WES data
at four-digit resolution. We found that a fraction of pub-
licly available WES data they used overlapped with our
dataset. Therefore, we checked these overlapped alleles
and compared the performance of their method with
ours. We found that PHLAT mistyped five alleles out of
the 100 alleles, three of which were mistyped at two-
digit resolution. HLAreporter outperformed PHLAT
with 100% accuracy at four-digit resolution. Notably,
these 100 alleles are covered with high quality reads and
high depth (Figure S4 in Additional file 1).
Meanwhile, Major et al.’s algorithm focused on class I
genes and reported 94% accuracy for WES data at four-
digit resolution. We tried to replicate their experiments
using their WES data but unfortunately their data failed
our data quality test (Figure S5 in Additional file 1). This
alignment-based algorithm still provides predictionsTable 3 HLA long haplotypes observed in our data and their
Haplotype HLA A-B-C-DRB1-DQB1 Frequency (
A*33:03-B*58:01-C*03:02-DRB1*03:01-DQB1*02:01 3.36
A*02:07-B*46:01-C*01:02-DRB1*14:01-DQB1*05:02 1.34
A*02:07-B*46:01-C*01:02-DRB1*04:05-DQB1*04:01 1.01
A*02:07-B*46:01-C*01:02-DRB1*09:01-DQB1*03:03 1.68
A*11:01-B*13:01-C*03:04-DRB1*16:02-DQB1*05:02 0.67
A*11:01-B*15:02-C*08:01-DRB1*15:01-DQB1*06:01 1.68
A*11:01-B*15:02-C*08:01-DRB1*12:02-DQB1*03:01 3.02
aFull names of the populations in the database are USA Asian pop 2 (USA Asian), V
minority (G), USA Hispanic pop 2 (Hispanic), China Yunan (Yunan). bThis population
in this Yunnan group with small sample size are not shown.even when the coverage depth is as low as three fold
[21]. These data with low coverage depth on the HLA
region might only be suitable for an alignment-based ap-
proach instead of a de novo assembly-based approach
such as HLAreporter. We simulated 60 samples based
on data used in Major et al.’s report (30 WES samples
and 30 WGS samples), and correctly predicted all HLA
alleles from these samples (see Table S5 in Additional
file 1 for details). The simulation suggested that the pro-
posed method also applies to WGS data. For RNAseq
data, however, given that the CRP was designed to col-
lect certain short reads with intronic sequences, it might
not properly capture the short reads covering exon-exon
junctions during mapping; thus, some modification is
needed to apply HLAreporter for RNAseq data.
In the current method we propose, only the main
exons of HLA genes are examined. These exons deter-
mine the amino acid residues of the peptide binding
groove that is important for antigen presentation. Yet,
there could be a small number of HLA alleles that share
identical sequences on the main polymorphic exons
while exhibiting polymorphism on other exons, such as
between the class I gene C*01:02:01 and C*01:02:11 al-
leles and between the class II gene DRB1*12:01:01 and
DRB1*12:10 alleles. Relatively, these sequences are less
important to the binding specificity of the encoded pro-
tein [22]. To reach an even higher resolution, further
analysis of additional exons would be needed for these
alleles.
With efficient HLA calling, analysis such as HLA allele
distribution profiles, haplotype prediction, and disease-
drug response association studies could be carried out
using available NGS data. Indeed, HLA allele frequency
estimated here is very consistent with the profile re-
ported from AFND [20]. Interestingly, certain long hap-
lotypes across nearly the entire core MHC region (about
4 Mb) were also observed (Table 3). Although the power
is low to accurately estimate the real frequency of these
extremely long haplotypes with merely 149 samples, the
enrichment of different haplotypes seen in Hong Kongpopulation distribution records in a public database
%) Population in DBa DB frequency (%)
USA Asian; V; SK; G 2.21; 3.50; 1.90; 0.25
USA Asianb 0.13
USA Asian 0.11
USA Asian 1.54; 2.00
USA Asian; Hispanic 0.18; 0.05
USA Asian 0.31
USA Asian; Yunnanc 1.41; 1.70-3.40
ietnam Hanoi Kinh pop 2 (V), South Korea pop 3 (SK), Germany DKMS-Turkey
has a relatively large sample size of 1,772 in the database. cSeveral populations
Huang et al. Genome Medicine  (2015) 7:25 Page 11 of 12Chinese is consistent with the frequencies of Asian pop-
ulations in public databases. In summary, the method in-
troduced here is timely and may help us make full use of
NGS data and to better connect the alleles in this region
with diseases, drug responses, and transplant rejections.
Conclusion
This study presents a novel technique for HLA typing
from whole exome sequencing data or other NGS data,
capable of accurate typing of HLA alleles at high-digit
resolution. Accurate HLA typing from NGS data holds
much promise for applications in clinical laboratories and
biomedical research. Preliminary analysis on both public
and local datasets indicates a great potential for broad ap-
plication of this method.
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Additional file 1: Table S1. Exome sequencing data with 601 (top for
HapMap data) and 110 known HLA alleles (middle for 1000 Genomes
data) and representatives of our 149 NGS samples generated in-house
(bottom). Table S2. HLA predictions of class I and II genes for 51
HapMap samples (top) and 20 internal samples from Thai population
(bottom). Table S3. Samples with phase issues. Table S4. Average
depth of assembled contigs on the exon 2 region which supported
the predictions of the HLA-DRB1 gene. Figure S1. HLA-DRB1 Prediction
of sample PaedA51 is consistent with the PCR-based results. Figure S2.
Integrative Genomics Viewer image of two samples, PaedA33 and
A52 (a) heterozygosity and (b) homozygosity. Figure S3. HLA allele
frequency in the Hong Kong Chinese population. Figure S4. Depth
test for sequencing reads of five 1000 Genome samples captured by
our comprehensive reference panel. Two thresholds of 50- and 30-fold
are indicated in the Figure. Figure S5. (a) Depth test for sequencing reads
of sample SRR081230 captured by our comprehensive reference panel. Two
thresholds of 20- and 30-fold are indicated in the Figure. (b) The number of
all informative reads without sequencing error contained in 30 samples. It
shows that even though these reads are equally distributed on the targeted
exons and are fully captured by the mapping panel, there are still too few
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predictions of class I genes for 60 WES and WGS samples.
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